FIELD: medicine.
SUBSTANCE: disclosed are aggregate antigen construct, method for production thereof, vaccine preparation containing the same, and uses thereof. Antigen aggregated construct having size of 30-500 nm improves immunogenicity of target preparation and differential recognition by immune system. Method for production claimed construct includes selection of necessary antigen, addition of said antigen into medium advancing to aggregation process, mixture incubation for 24 hours-7 days at 28°C and collection of aggregate particle having size form 30 to 500 nm for example by gel filtration, ultrafiltration or dialysis. Invention is useful in vaccine production.
EFFECT: antigens with increased immunogenicity.
33 cl, 19 dwg, 1 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE COMPOSITION POTENTIATED WITH DNA AND ANTIGEN COMBINATION | 2002 |
|
RU2294212C2 |
| PHARMACEUTICAL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2004 |
|
RU2362586C2 |
| AGENTS AND METHODS OF TREATING HEPATITIS B VIRUS | 2017 |
|
RU2740802C2 |
| POLYEPITOPIC ANTI-HEPATITIS B VACCINE OF 4-TH GENERATION AND METHOD OF OBTAINING IT | 2011 |
|
RU2469741C1 |
| ANTIGEN TAU-PEPTIDES AND THEIR APPLICATION | 2010 |
|
RU2518291C2 |
| VACCINAL COMPOSITION AGAINST HEPATITIS C VIRUS | 2005 |
|
RU2351363C2 |
| RECOMBINANT PLASMIDE DNA pU8HBc-preS1, ENCODING PROTEIN GENE OF HEPATITIS B VIRUS CORE ANTIGEN INCLUDING pre-S1 REGION EPITOPE OF HEPATITIS B VIRUS SURFACE PROTEIN AND BACTERIUM STRAIN Escherichia coli AR PRODUCER OF HYBRID HBc-preS1 PROTEIN | 2005 |
|
RU2295570C2 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
| CONJUGATE OF ANGIOTENSIN PEPTIDE COMPONENT WITH CARRIER, VACCINE COMPOSITION, METHOD OF ANIMAL IMMUNISATION AND METHOD OF TREATMENT OR PREVENTION OF PHYSICAL DISORDER RELATED TO ANGIOTENSIN SYSTEM ACTIVATED BY RENIN | 2002 |
|
RU2350622C2 |
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
